GWP GW Pharm.

RNS Number:6153L
GW Pharmaceuticals PLC
15 October 2001

                                 SCHEDULE 11

         NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS

  Name of Company

  G W Pharmaceuticals plc

  Name of Director

  David Francis Kirk

  Please state whether notification indicates that it is in respect of holding
  of the shareholder named in 2 above or in respect of a non-beneficial
  interest or in the case of an individual holder if it is a holding of that
  person's spouse or children under the age of 18 or in respect of a
  non-beneficial interest

  As in 2 above

  Name of the registered holder(s) and, if more than one holder, the number of
  shares held by each of them (if notified)

  David Francis Kirk

  Please state whether notification relates to a person(s) connected with the
  Director named in 2 above and identify the connected person(s)

  As in 2 above

  Please state the nature of the transaction. For PEP transactions please
  indicate whether general/single co PEP and if discretionary/non discretionary

  Purchase of Ordinary Shares

  Number of shares/amount of stock acquired

  6,000

  Percentage of issued class

  0.006%

  Number of shares/amount of stock disposed

  N/A

  Percentage of issued class

  N/A

  Class of security

  Ordinary Shares

  Price per share

  81p

  Date of transaction

  15th October 2001

  Date company informed

  15th October 2001

  Total holding following this notification

  6,000

  Total percentage holding of issued class following this notification

  0.006%

If a director has been granted options by the company please complete the
following boxes

17) Date of grant

18) Period during which or date on which exercisable

19) Total amount paid (if any) for grant of the option

20) Description of shares or debentures involved: class, number

21) Exercise price (if fixed at time of grant) or indication that price is to
    be fixed at time of exercise

22) Total number of shares or debentures over which options held following this
    notification



23) Any additional information



24) Name of contact and telephone number for queries

    David Kirk, +44 (020) 7958 9733

25) Name and signature of authorised company official responsible for making
    this notification

    David Kirk, Finance Director

Date of Notification: 15th October 2001

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024